Article Details

Sparrow Pharmaceuticals: $95 Million Series B Raised For Advancing Targeted Therapy For ...

Retrieved on: 2025-09-27 09:04:59

Tags for this article:

Click the tags to see associated articles and topics

Sparrow Pharmaceuticals: $95 Million Series B Raised For Advancing Targeted Therapy For .... View article details on hiswai:

Excerpt

... Capital Management and Forbion, and also received continued support from existing investors, including OrbiMed, RiverVest, and US Venture Partners.

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo